Concepedia

Lindsay L. Brown

LL

Statistics

Publications

6

Citations

541

H-Index

6

Active since

2005

Affiliations

Seagen (United States)(Current)

Siga Technologies (United States)

Lindsay L. Brown is an author at Seagen (United States) specializing in oncology, antibody-drug conjugates, and molecular oncology.

Publications per year

2005–2008

6

Publications

6

Vaccination of BALB/c Mice with<i>Escherichia coli</i>-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge

Aklile Berhanu, Rebecca L. Wilson, Dana L. Kirkwood-Watts et al. · Journal of Virology · 2008 · 102 citations · Full text

, , +17

Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index

Charlotte F. McDonagh, Kristine M. Kim, Eileen Turcott et al. · Molecular Cancer Therapeutics · 2008 · 96 citations

, , +17

Anti-CD30 diabody-drug conjugates with potent antitumor activity

Kristine M. Kim, Charlotte F. McDonagh, Lori Westendorf et al. · Molecular Cancer Therapeutics · 2008 · 93 citations

, , +17

Antibody targeting of B-cell maturation antigen on malignant plasma cells

Maureen C. Ryan, Michelle A. Hering, D. W. Peckham et al. · Molecular Cancer Therapeutics · 2007 · 87 citations · Full text

, , +17

<i>Listeria monocytogenes</i>10403S HtrA Is Necessary for Resistance to Cellular Stress and Virulence

Rebecca L. Wilson, Lindsay L. Brown, Dana L. Kirkwood-Watts et al. · Infection and Immunity · 2005 · 82 citations · Full text

, , +17

1–5 of 6